Fulcrum Therapeutics, Inc. (FULC)
NASDAQ·Healthcare·Biotechnology
$3.70
+1.65%
Mkt Cap $282.30M
Analyst Ratings
Buy
0
Hold
3
Sell
2
Price Target (31 analysts)
$3.60
Range $3.00 – $4.00
Implied Upside
-2.7%
Consensus $3.60 vs current $3.70
NASDAQ·Healthcare·Biotechnology
$3.70
+1.65%
Mkt Cap $282.30M
Buy
0
Hold
3
Sell
2
Price Target (31 analysts)
$3.60
Range $3.00 – $4.00
-2.7%
Consensus $3.60 vs current $3.70